SEC Filing | Veradigm Inc.

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

LEISHER THOMAS S

(Last)

(First)

(Middle)

222 MERCHANDISE MART PLAZA

SUITE 2024

(Street)

CHICAGO

60654

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/18/2007

3. Issuer Name and Ticker or Trading Symbol
ALLSCRIPTS HEALTHCARE SOLUTIONS INC [ MDRX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
President, eRx

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	48,070	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	⁽¹⁾	12/31/2014	Common Stock	25,000	10.67	D
Stock Option (right to buy)	⁽²⁾	04/01/2014	Common Stock	20,000	9.49	D
Stock Option (right to buy)	⁽³⁾	06/24/2013	Common Stock	42,000	3.53	D
Stock Option (right to buy)	⁽⁴⁾	07/26/2011	Common Stock	35,000	6.75	D
Stock Option (right to buy)	⁽⁵⁾	03/01/2011	Common Stock	52,000	5.63	D

Explanation of Responses:

1. Stock option granted on December 31, 2004 ("Grant Date") under the Allscripts Healthcare Solutions, Inc. 1993 Stock Incentive Plan. The stock option vested 33% on the Grant Date and 67% on December 31, 2005.

2. Stock option granted on April 1, 2004 ("Grant Date") under the Allscripts Healthcare Solutions, Inc. 1993 Stock Incentive Plan. The stock option vested 100% on the Grant Date.

3. Stock option granted on June 24, 2003 ("Grant Date") under the Allscripts Healthcare Solutions, Inc. 1993 Stock Incentive Plan. The stock option vested 25% on the Grant Date, 25% on June 24, 2004 and 2005, and 25% on December 31, 2005.

4. Stock option granted on July 26, 2001 under the Allscripts Healthcare Solutions, Inc. 1993 Stock Incentive Plan. The stock option vested in four equal annual installments beginning on July 26, 2002.

5. Stock option granted on March 1, 2001 under the Allscripts Healthcare Solutions, Inc. 1993 Stock Incentive Plan. The stock option vested in four equal annual installments beginning on March 1, 2002.

	Jena Kluska for Thomas S. Leisher by Power of Attorney	04/27/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

rrd137163_154378.html


						       EXHIBIT 24

                            POWER OF ATTORNEY

     Know all by these presents, that the undersigned hereby constitutes
and appoints each of Jena Kluska, Gina Nienberg, Kathie Kittner, Greg
Swanson and William Davis, signing singly, the undersigned's true and
lawful attorney-in-fact to:
     (1) execute for and on behalf of the undersigned, all reports to be
filed by the undersigned pursuant to Section 16(a) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") and the rules
promulgated thereunder (including Forms 3, 4, and 5 and any successor forms)
(the "Section 16 Reports") with respect to the equity securities of
Allscripts Healthcare Solutions, Inc. (the "Company");
     (2) do and perform any and all acts for and on behalf of the
undersigned that may be necessary or desirable to complete and execute any
such Section 16 Report, complete and execute any amendment or amendments
thereto, and file such report with the United States Securities and
Exchange Commission and any stock exchange or similar authority; and
     (3) take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it
being understood that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
     The powers granted above may be exercised by each such
attorney-in-fact on behalf of the undersigned, individually, and on behalf of
the undersigned in any fiduciary or representative capacity in which the
undersigned may be acting.
     The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted.  The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of
the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
     This Power of Attorney shall be effective as of the date set forth
below and shall continue in full force and effect until the undersigned is no
longer required to file Section 16 Reports with respect to the equity
securities of the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 18th day of April, 2007.



                                   By:         _____/s/ Thomas Scott Leisher _____
                                                          Thomas Scott Leisher